Health Condition 1: I219- Acute myocardial infarction, unspecified
Conditions
Interventions
Intervention1: Adjuvant: Bioticas - 5 billion CFU per day, twice a day (BD), oral for 12 weeks
Control Intervention1: Bioticas: Lactobacillus acidophillus, Lactobacillus
rhamnosus, Bifidobacterium lon
Sponsors
Individual
Eligibility
Inclusion criteria
Inclusion criteria: Both Inpatients & Outpatients above 18 and below 75 years. Patients who has been diagnosed with Myocardial Infarction. Patients who agrees to participate by knowing the nature and objectives of the study, and willing to take the Informed consent. Patients with elevated LDL cholesterol levels greater than 100 mg per dL and or increased hs-CRP levels greater than or equal to 3 mg per L. Patients with documented left ventricular dysfunction Ejection Fraction less than or equal to 50%
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant decrease in hs-CRP levels, indicating reduced systemic inflammation and lower cardiovascular risk. Reduction in LDL cholesterol levels, contributing to decreased atherosclerosis progression and better lipid metabolism regulation. Improvement in left ventricular ejection fraction (LVEF) and other echocardiographic markers, suggesting better myocardial recovery and function. Patients receiving probiotics may experience better clinical recovery, reduced risk of recurrent cardiac events, and improved treatment satisfaction.Timepoint: 6 months data collections | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDr SP Santhosh Kumar
Vivekanandha Medical Care Hospital
Outcome results
None listed